TH
MDCO

Timber Hill’s Medicines Co MDCO Stock Holding History

Timber Hill’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-28,000
Closed -$766K – 660
2017
Q4 		$766K Sell
28,000
-5,100
-15% -$157K 0.05% 330
2017
Q3 		$1.23M Sell
33,100
-2,000
-6% -$73.7K 0.11% 162
2017
Q2 		$1.33M Buy
35,100
+12,600
+56% +$561K 0.05% 288
2017
Q1 		$1.1M Sell
22,500
-800
-3% -$36.5K 0.01% 1012
2016
Q4 		$791K Sell
23,300
-17,100
-42% -$606K ﹤0.01% 1411
2016
Q3 		$1.52M Buy
+40,400
New +$1.52M 0.01% 913
2016
Q2 		– Sell
-8,000
Closed -$254K – 2386
2016
Q1 		$254K Buy
+8,000
New +$261K ﹤0.01% 1856
2015
Q4 		– Sell
-8,100
Closed -$307K – 2563
2015
Q3 		$307K Buy
+8,100
New +$284K ﹤0.01% 2034
2014
Q3 		– Sell
-31,200
Closed -$907K – 2913
2014
Q2 		$907K Buy
31,200
+13,200
+73% +$353K ﹤0.01% 1721
2014
Q1 		$512K Buy
18,000
+6,000
+50% +$199K ﹤0.01% 2027
2013
Q4 		$463K Sell
12,000
-1,800
-13% -$64.4K ﹤0.01% 2339
2013
Q3 		$463K Sell
13,800
-23,000
-63% -$733K ﹤0.01% 2503
2013
Q2 		$1.13M Buy
+36,800
New +$1.23M ﹤0.01% 1855

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Timber Hill's MDCO Position: Q2 2017 in Review

Timber Hill sold out of Medicines Co (MDCO) in Q2 2017, closing a stake of 6,476 shares — an estimated $288K sold.

Timber Hill first reported a position in MDCO in Q3 2013 and held it in 3 quarters. The position peaked at $751K in Q3 2013. 202 funds tracked by Wall St. Rank hold MDCO as of Q2 2017.

  • Timber Hill reported no remaining Medicines Co position as of Q2 2017 after selling out during the quarter.
  • Timber Hill sold 6,476 Medicines Co shares in Q2 2017, an estimated $288K.
  • Timber Hill first reported a position in Medicines Co in Q3 2013 and held it in 3 quarters.
  • Timber Hill's Medicines Co position peaked at $751K in Q3 2013.
  • 202 funds tracked by Wall St. Rank held Medicines Co as of Q2 2017.

Based on Timber Hill's 13F filing for Q2 2017, filed 9 Aug 2017.